Genmab | GEN - Umlaufvermögen

Aktienkurs
1,702.50
Täglich Wechseln
-38.00 -2.18%
Monatlich
-9.01%
Jährlich
20.40%
Q1 Prognose
1,614.31




Umlaufvermögen Veränderung Datum
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Almirall EUR 713.98M 69K 2025-12
Amarin USD 628.33M 21.52M 2025-09
Amgen USD 29.06B 1.17B 2025-12
argenx SE USD 5.83B 946.64M 2025-06
AstraZeneca USD 28.72B 1.22B 2025-12
Bayer EUR 32.91B 30M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Demant DKK 10.08B 128M 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Fresenius Medical Care EUR 7.9B 74M 2025-12
Galapagos EUR 3.08B 82.56M 2025-12
Genmab DKK 3.91B 127M 2025-06
GlaxoSmithKline GBP 17.51B 332M 2025-12
GN Store Nord DKK 8.64B 105M 2025-12
GRIFOLS EUR 5.07B 274.77M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Insmed USD 1.79B 137.6M 2025-12
Lonza CHF 5.44B 113M 2024-12
Merck EUR 13.23B 354M 2025-12
Novartis USD 28.2B 2.26B 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.95B 3.09B 2025-12
UCB EUR 4.79B 1.47B 2024-12